Cessation Clinical Trial
- Conditions
- Tobacco Use Cessation
- Registration Number
- NCT06806098
- Lead Sponsor
- Truth Initiative
- Brief Summary
The Cessation Clinical Trial will investigate the effectiveness of a digital quit tobacco program in promoting abstinence from tobacco product use compared to usual care.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- RECRUITING
- Sex
- All
- Target Recruitment
- 2220
- Current tobacco use (past 30-day use of one or more of the following: cigarettes, cigars, little cigars, cigarillos, e-cigarettes, or oral nicotine products)
- US residence
- Active text message plan (phase 2 only)
- Age 25 or above (phase 2 only)
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Primary Outcome Measures
Name Time Method 30-day point prevalent abstinence 7-months post randomization 30-day point prevalent abstinence from user's primary product to quit indicated at enrollment
- Secondary Outcome Measures
Name Time Method Abstinence from all tobacco products 7 months post randomization Abstinence from any combustible tobacco product and any nicotine-containing product.
Past 30-day abstinence will be measured for the following tobacco/nicotine products one by one and a combined total abstinence measure will be calculated based on these responses.
Measurement item:
In the past 30 days, which of the following products have you used at all (i.e., even a puff/hit)? Response options are Yes/No for each item.
* Cigarettes
* E-cigarettes
* Chew
* Dip
* Nicotine pouches
* Cigars/little cigars/cigarillos
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
Trial Locations
- Locations (1)
Truth Initiative
🇺🇸Washington, District of Columbia, United States